While EZH2-dependent transcriptional activation in colon cancer arises independently of the protein’s methyltransferase activity [49], the activating transcriptional properties of EZH2 in castration-resistant prostate cancer rely on its methyltransferase activity, but do not occur in concert with the other PRC2 components [21]. This evidence concerns the gene EZH2 and colonic neoplasm.